↓ Skip to main content

Natalizumab in the treatment of multiple sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natalizumab in the treatment of multiple sclerosis
Published in
Therapeutics and Clinical Risk Management, July 2009
DOI 10.2147/tcrm.s5218
Pubmed ID
Authors

Brandon A Brown

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Brazil 1 4%
Unknown 22 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 21%
Student > Doctoral Student 2 8%
Student > Bachelor 2 8%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Other 1 4%
Unknown 10 42%
Readers by discipline Count As %
Medicine and Dentistry 7 29%
Biochemistry, Genetics and Molecular Biology 3 13%
Agricultural and Biological Sciences 2 8%
Economics, Econometrics and Finance 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 0 0%
Unknown 10 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2019.
All research outputs
#3,798,287
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#188
of 1,323 outputs
Outputs of similar age
#14,355
of 122,278 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 13 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,278 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.